 | • レポートコード：MRC2-11QY12540 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は下部消化管シリーズのグローバル市場について調査・分析したレポートです。種類別（ダブルコントラスト、シングルコントラスト）市場規模、用途別（胃腸炎、大腸ポリープ、腫瘍、狭窄クローン病、潰瘍性大腸炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別下部消化管シリーズの競争状況、市場シェア ・世界の下部消化管シリーズ市場：種類別市場規模 2015年-2020年（ダブルコントラスト、シングルコントラスト） ・世界の下部消化管シリーズ市場：種類別市場規模予測 2021年-2026年（ダブルコントラスト、シングルコントラスト） ・世界の下部消化管シリーズ市場：用途別市場規模 2015年-2020年（胃腸炎、大腸ポリープ、腫瘍、狭窄クローン病、潰瘍性大腸炎、その他） ・世界の下部消化管シリーズ市場：用途別市場規模予測 2021年-2026年（胃腸炎、大腸ポリープ、腫瘍、狭窄クローン病、潰瘍性大腸炎、その他） ・北米の下部消化管シリーズ市場分析：米国、カナダ ・ヨーロッパの下部消化管シリーズ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの下部消化管シリーズ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の下部消化管シリーズ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの下部消化管シリーズ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eisai、Cadila Pharmaceuticals、Purdue Pharma、Peacehealth、Novadaq、Astrazeneca、Ironwood Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.
Market Analysis and Insights: Global Lower GI Series Market
The global Lower GI Series market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lower GI Series Scope and Market Size
Lower GI Series market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lower GI Series market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals
…
Market segment by Type, the product can be split into
Double-Contrast
Single-Contrast
Market segment by Application, split into
Gastroenteritis
Colon Polyps
Tumor
Strictures Crohn’s Disease
Ulcerative Colitis
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lower GI Series Revenue
1.4 Market by Type
1.4.1 Global Lower GI Series Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Double-Contrast
1.4.3 Single-Contrast
1.5 Market by Application
1.5.1 Global Lower GI Series Market Share by Application: 2020 VS 2026
1.5.2 Gastroenteritis
1.5.3 Colon Polyps
1.5.4 Tumor
1.5.5 Strictures Crohn’s Disease
1.5.6 Ulcerative Colitis
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lower GI Series Market Perspective (2015-2026)
2.2 Global Lower GI Series Growth Trends by Regions
2.2.1 Lower GI Series Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lower GI Series Historic Market Share by Regions (2015-2020)
2.2.3 Lower GI Series Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lower GI Series Market Growth Strategy
2.3.6 Primary Interviews with Key Lower GI Series Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lower GI Series Players by Market Size
3.1.1 Global Top Lower GI Series Players by Revenue (2015-2020)
3.1.2 Global Lower GI Series Revenue Market Share by Players (2015-2020)
3.1.3 Global Lower GI Series Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lower GI Series Market Concentration Ratio
3.2.1 Global Lower GI Series Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lower GI Series Revenue in 2019
3.3 Lower GI Series Key Players Head office and Area Served
3.4 Key Players Lower GI Series Product Solution and Service
3.5 Date of Enter into Lower GI Series Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lower GI Series Historic Market Size by Type (2015-2020)
4.2 Global Lower GI Series Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lower GI Series Market Size by Application (2015-2020)
5.2 Global Lower GI Series Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lower GI Series Market Size (2015-2020)
6.2 Lower GI Series Key Players in North America (2019-2020)
6.3 North America Lower GI Series Market Size by Type (2015-2020)
6.4 North America Lower GI Series Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lower GI Series Market Size (2015-2020)
7.2 Lower GI Series Key Players in Europe (2019-2020)
7.3 Europe Lower GI Series Market Size by Type (2015-2020)
7.4 Europe Lower GI Series Market Size by Application (2015-2020)
8 China
8.1 China Lower GI Series Market Size (2015-2020)
8.2 Lower GI Series Key Players in China (2019-2020)
8.3 China Lower GI Series Market Size by Type (2015-2020)
8.4 China Lower GI Series Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lower GI Series Market Size (2015-2020)
9.2 Lower GI Series Key Players in Japan (2019-2020)
9.3 Japan Lower GI Series Market Size by Type (2015-2020)
9.4 Japan Lower GI Series Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lower GI Series Market Size (2015-2020)
10.2 Lower GI Series Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lower GI Series Market Size by Type (2015-2020)
10.4 Southeast Asia Lower GI Series Market Size by Application (2015-2020)
11 India
11.1 India Lower GI Series Market Size (2015-2020)
11.2 Lower GI Series Key Players in India (2019-2020)
11.3 India Lower GI Series Market Size by Type (2015-2020)
11.4 India Lower GI Series Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lower GI Series Market Size (2015-2020)
12.2 Lower GI Series Key Players in Central & South America (2019-2020)
12.3 Central & South America Lower GI Series Market Size by Type (2015-2020)
12.4 Central & South America Lower GI Series Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eisai
13.1.1 Eisai Company Details
13.1.2 Eisai Business Overview
13.1.3 Eisai Lower GI Series Introduction
13.1.4 Eisai Revenue in Lower GI Series Business (2015-2020))
13.1.5 Eisai Recent Development
13.2 Cadila Pharmaceuticals
13.2.1 Cadila Pharmaceuticals Company Details
13.2.2 Cadila Pharmaceuticals Business Overview
13.2.3 Cadila Pharmaceuticals Lower GI Series Introduction
13.2.4 Cadila Pharmaceuticals Revenue in Lower GI Series Business (2015-2020)
13.2.5 Cadila Pharmaceuticals Recent Development
13.3 Purdue Pharma
13.3.1 Purdue Pharma Company Details
13.3.2 Purdue Pharma Business Overview
13.3.3 Purdue Pharma Lower GI Series Introduction
13.3.4 Purdue Pharma Revenue in Lower GI Series Business (2015-2020)
13.3.5 Purdue Pharma Recent Development
13.4 Peacehealth
13.4.1 Peacehealth Company Details
13.4.2 Peacehealth Business Overview
13.4.3 Peacehealth Lower GI Series Introduction
13.4.4 Peacehealth Revenue in Lower GI Series Business (2015-2020)
13.4.5 Peacehealth Recent Development
13.5 Novadaq
13.5.1 Novadaq Company Details
13.5.2 Novadaq Business Overview
13.5.3 Novadaq Lower GI Series Introduction
13.5.4 Novadaq Revenue in Lower GI Series Business (2015-2020)
13.5.5 Novadaq Recent Development
13.6 Astrazeneca
13.6.1 Astrazeneca Company Details
13.6.2 Astrazeneca Business Overview
13.6.3 Astrazeneca Lower GI Series Introduction
13.6.4 Astrazeneca Revenue in Lower GI Series Business (2015-2020)
13.6.5 Astrazeneca Recent Development
13.7 Ironwood Pharmaceuticals
13.7.1 Ironwood Pharmaceuticals Company Details
13.7.2 Ironwood Pharmaceuticals Business Overview
13.7.3 Ironwood Pharmaceuticals Lower GI Series Introduction
13.7.4 Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2015-2020)
13.7.5 Ironwood Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lower GI Series Key Market Segments
Table 2. Key Players Covered: Ranking by Lower GI Series Revenue
Table 3. Ranking of Global Top Lower GI Series Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lower GI Series Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Double-Contrast
Table 6. Key Players of Single-Contrast
Table 7. Global Lower GI Series Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Lower GI Series Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Lower GI Series Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Lower GI Series Market Share by Regions (2015-2020)
Table 11. Global Lower GI Series Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Lower GI Series Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Lower GI Series Market Growth Strategy
Table 17. Main Points Interviewed from Key Lower GI Series Players
Table 18. Global Lower GI Series Revenue by Players (2015-2020) (Million US$)
Table 19. Global Lower GI Series Market Share by Players (2015-2020)
Table 20. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower GI Series as of 2019)
Table 21. Global Lower GI Series by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lower GI Series Product Solution and Service
Table 24. Date of Enter into Lower GI Series Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 27. Global Lower GI Series Market Size Share by Type (2015-2020)
Table 28. Global Lower GI Series Revenue Market Share by Type (2021-2026)
Table 29. Global Lower GI Series Market Size Share by Application (2015-2020)
Table 30. Global Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 31. Global Lower GI Series Market Size Share by Application (2021-2026)
Table 32. North America Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Lower GI Series Market Share (2019-2020)
Table 34. North America Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 35. North America Lower GI Series Market Share by Type (2015-2020)
Table 36. North America Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 37. North America Lower GI Series Market Share by Application (2015-2020)
Table 38. Europe Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Lower GI Series Market Share (2019-2020)
Table 40. Europe Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Lower GI Series Market Share by Type (2015-2020)
Table 42. Europe Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Lower GI Series Market Share by Application (2015-2020)
Table 44. China Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 45. China Key Players Lower GI Series Market Share (2019-2020)
Table 46. China Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 47. China Lower GI Series Market Share by Type (2015-2020)
Table 48. China Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 49. China Lower GI Series Market Share by Application (2015-2020)
Table 50. Japan Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Lower GI Series Market Share (2019-2020)
Table 52. Japan Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Lower GI Series Market Share by Type (2015-2020)
Table 54. Japan Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Lower GI Series Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Lower GI Series Market Share (2019-2020)
Table 58. Southeast Asia Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Lower GI Series Market Share by Type (2015-2020)
Table 60. Southeast Asia Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Lower GI Series Market Share by Application (2015-2020)
Table 62. India Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 63. India Key Players Lower GI Series Market Share (2019-2020)
Table 64. India Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 65. India Lower GI Series Market Share by Type (2015-2020)
Table 66. India Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 67. India Lower GI Series Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Lower GI Series Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Lower GI Series Market Share (2019-2020)
Table 70. Central & South America Lower GI Series Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Lower GI Series Market Share by Type (2015-2020)
Table 72. Central & South America Lower GI Series Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Lower GI Series Market Share by Application (2015-2020)
Table 74. Eisai Company Details
Table 75. Eisai Business Overview
Table 76. Eisai Product
Table 77. Eisai Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 78. Eisai Recent Development
Table 79. Cadila Pharmaceuticals Company Details
Table 80. Cadila Pharmaceuticals Business Overview
Table 81. Cadila Pharmaceuticals Product
Table 82. Cadila Pharmaceuticals Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 83. Cadila Pharmaceuticals Recent Development
Table 84. Purdue Pharma Company Details
Table 85. Purdue Pharma Business Overview
Table 86. Purdue Pharma Product
Table 87. Purdue Pharma Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 88. Purdue Pharma Recent Development
Table 89. Peacehealth Company Details
Table 90. Peacehealth Business Overview
Table 91. Peacehealth Product
Table 92. Peacehealth Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 93. Peacehealth Recent Development
Table 94. Novadaq Company Details
Table 95. Novadaq Business Overview
Table 96. Novadaq Product
Table 97. Novadaq Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 98. Novadaq Recent Development
Table 99. Astrazeneca Company Details
Table 100. Astrazeneca Business Overview
Table 101. Astrazeneca Product
Table 102. Astrazeneca Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 103. Astrazeneca Recent Development
Table 104. Ironwood Pharmaceuticals Company Details
Table 105. Ironwood Pharmaceuticals Business Overview
Table 106. Ironwood Pharmaceuticals Product
Table 107. Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2015-2020) (Million US$)
Table 108. Ironwood Pharmaceuticals Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lower GI Series Market Share by Type: 2020 VS 2026
Figure 2. Double-Contrast Features
Figure 3. Single-Contrast Features
Figure 4. Global Lower GI Series Market Share by Application: 2020 VS 2026
Figure 5. Gastroenteritis Case Studies
Figure 6. Colon Polyps Case Studies
Figure 7. Tumor Case Studies
Figure 8. Strictures Crohn's Disease Case Studies
Figure 9. Ulcerative Colitis Case Studies
Figure 10. Others Case Studies
Figure 11. Lower GI Series Report Years Considered
Figure 12. Global Lower GI Series Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Lower GI Series Market Share by Regions: 2020 VS 2026
Figure 14. Global Lower GI Series Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Lower GI Series Market Share by Players in 2019
Figure 17. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower GI Series as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Lower GI Series Revenue in 2019
Figure 19. North America Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Lower GI Series Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…- 潰瘍性大腸炎免疫薬 の世界市場（～2026年） Market Analysis and Insights: Global Ulcerative Colitis Immunology Drugs Market The global Ulcerative Colitis Immunology Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ulcerative Colitis Immunology Drugs Scope a…
- マイクロバブル/超音波造影剤の世界市場（～2026年） Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…
- 診断用放射性医薬品・造影剤の世界市場（～2026年） Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. The market drivers are technology advancements in medical imaging, increasing demand for image guided procedures and…
- MRI造影剤の世界市場（～2026年） MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues …